Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cyproterone acetate preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate 100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate [acne] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate and ethinylestradiol adverse reaction |
Causative agent (attribute) |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to cyproterone acetate and ethinylestradiol |
Causative agent (attribute) |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate+ethinyloestradiol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate 100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyproterone acetate 100mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cyproterone acetate and ethinylestradiol |
Causative agent (attribute) |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
Has precise active ingredient |
False |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyproterone acetate 100mg tablet (substance) |
Has precise active ingredient |
True |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
Has precise active ingredient |
True |
Cyproterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |